Trial · NCT01707992
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Placebo-Controlled Phase (24 Months) | STARTED | Placebo-Controlled Phase: Placebo | 740 | |
| Placebo-Controlled Phase (24 Months) | STARTED | Placebo-Controlled Phase: Laquinimod 0.6 mg | 727 | |
| Placebo-Controlled Phase (24 Months) | STARTED | Placebo-Controlled Phase: Laquinimod 1.2 mg | 732 | |
| Placebo-Controlled Phase (24 Months) | STARTED | Active Treatment Phase: Laquinimod 0.6 mg | 0 | |
| Placebo-Controlled Phase (24 Months) | STARTED | Active Treatment Phase: Laquinimod 1.2 mg | 0 | |
| Placebo-Controlled Phase (24 Months) | STARTED | Active Treatment Phase: Off Drug | 0 | |
| Placebo-Controlled Phase (24 Months) | COMPLETED | Placebo-Controlled Phase: Placebo | 596 | |
| Placebo-Controlled Phase (24 Months) | COMPLETED | Placebo-Controlled Phase: Laquinimod 0.6 mg | 623 | |
| Placebo-Controlled Phase (24 Months) | COMPLETED | Placebo-Controlled Phase: Laquinimod 1.2 mg | 532 | |
| Placebo-Controlled Phase (24 Months) | COMPLETED | Active Treatment Phase: Laquinimod 0.6 mg | 0 | |
| Placebo-Controlled Phase (24 Months) | COMPLETED | Active Treatment Phase: Laquinimod 1.2 mg | 0 | |
| Placebo-Controlled Phase (24 Months) | COMPLETED | Active Treatment Phase: Off Drug | 0 | |
| Placebo-Controlled Phase (24 Months) | NOT COMPLETED | Placebo-Controlled Phase: Placebo | 144 | |
| Placebo-Controlled Phase (24 Months) | NOT COMPLETED | Placebo-Controlled Phase: Laquinimod 0.6 mg | 104 | |
| Placebo-Controlled Phase (24 Months) | NOT COMPLETED | Placebo-Controlled Phase: Laquinimod 1.2 mg | 200 | |
| Placebo-Controlled Phase (24 Months) | NOT COMPLETED | Active Treatment Phase: Laquinimod 0.6 mg | 0 | |
| Placebo-Controlled Phase (24 Months) | NOT COMPLETED | Active Treatment Phase: Laquinimod 1.2 mg | 0 | |
| Placebo-Controlled Phase (24 Months) | NOT COMPLETED | Active Treatment Phase: Off Drug | 0 | |
| Active Treatment Phase (24 Months) | STARTED | Placebo-Controlled Phase: Placebo | 0 | |
| Active Treatment Phase (24 Months) | STARTED | Placebo-Controlled Phase: Laquinimod 0.6 mg | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01707992/flow